These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19716082)

  • 1. Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada.
    Krahn AD; Healey JS; Simpson CS; Essebag V; Sivakumaran S; Birnie DH
    Heart Rhythm; 2009 Sep; 6(9):1276-9. PubMed ID: 19716082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
    Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
    Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation bridging around device surgery: compliance with guidelines.
    Perrin MJ; Vezi BZ; Ha AC; Keren A; Nery PB; Birnie DH
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1480-6. PubMed ID: 22978770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.
    Nascimento T; Birnie DH; Healey JS; Verma A; Joza J; Bernier ML; Essebag V
    Can J Cardiol; 2014 Feb; 30(2):231-6. PubMed ID: 24461924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
    Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
    Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation management during cardiac device surgery: many tastes tolerated?
    van Hemel NM
    Heart Rhythm; 2009 Sep; 6(9):1280-1. PubMed ID: 19656737
    [No Abstract]   [Full Text] [Related]  

  • 12. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
    Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
    Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
    Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
    J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.
    Douketis JD; Crowther MA; Cherian SS
    Can J Cardiol; 2000 Mar; 16(3):326-30. PubMed ID: 10744795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of CHADS2 score on late stroke after the Cox maze procedure.
    Pet M; Robertson JO; Bailey M; Guthrie TJ; Moon MR; Lawton JS; Rinne A; Damiano RJ; Maniar HS
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):85-9. PubMed ID: 22818126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
    Daniels PR
    Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.